The European Commission addressed on 26 July a Statement of Objections under EU antitrust rules to Les Laboratoires Servier and Servier SAS (together «Servier»), a French pharmaceutical company. The Commission’s provisional view is that it has evidence that Servier has provided misleading and incorrect information in reply to a request for information in the context of the pharmaceutical competition sector inquiry. If, at the outcome of the investigation, the Commission concludes that there is sufficient evidence that Servier, intentionally or negligently, provided such misleading and incorrect information, it may impose a fine of up to 1% of the total turnover of the company in the preceding business year.